[Recommendations of good practice: medicines that induce ovulation (June 2003)].
D000328:Adult; D000858:Anovulation / Q000188:drug therapy; D002996:Clomiphene / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005307:Fertilization in Vitro; D005602:France / Q000453:epidemiology; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000819:agonists; D006062:Gonadotropins / Q000008:administration & dosage / Q000009:adverse effects / Q000652:urine; D006801:Humans; D007247:Infertility, Female / Q000453:epidemiology / Q000628:therapy; D007248:Infertility, Male / Q000453:epidemiology / Q000628:therapy; D007315:Insemination, Artificial; D008297:Male; D008875:Middle Aged; D010062:Ovulation Induction / Q000379:methods*; D010507:Periodicity; D011247:Pregnancy; D011272:Pregnancy, Multiple; D011994:Recombinant Proteins
D006062:Gonadotropins; D011994:Recombinant Proteins; D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone